Biologics License Application Archives - Express Pharma

Lerodalcibep can be a treatment option for patients requiring additional LDL-C reduction: GlobalData

US FDA accepts Amneal’s Biologics License Application for Bevacizumab

US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar

USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan

US FDA accepts Mylan and Biocon’s proposed biosimilar bevacizumab for review